As NRF2 has been reported to suppress FAO in other cancer contexts (42), its loss in pancreatic ductal cells may enable a FAO-driven metabolic shift that favors IPMN formation. This evidence concerns the gene NFE2L2 and pancreatic intraductal papillary-mucinous neoplasm.